Fig. 3.
Fig. 3. Estimates of survival. / Kaplan-Meier estimates of survival in recipients of unrelated donor UCB versus HLA-matched BM who received GVHD prophylaxis with MTX (BM-MTX) and UCB versus HLA-matched BM who received GVHD prophylaxis with TCD (BM-TCD). UCB versus BM-MTX, P = .40. UCB versus BM-TCD,P > .80.

Estimates of survival.

Kaplan-Meier estimates of survival in recipients of unrelated donor UCB versus HLA-matched BM who received GVHD prophylaxis with MTX (BM-MTX) and UCB versus HLA-matched BM who received GVHD prophylaxis with TCD (BM-TCD). UCB versus BM-MTX, P = .40. UCB versus BM-TCD,P > .80.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal